Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Ouwens

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Advances in Therapy|April 2, 2023
Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis"Jonathan Marshall, Akanksha Sharma, Patrick Darken, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 11, 2024
Associations between the EQ-5D-5L and exacerbations of chronic obstructive pulmonary disease in the ETHOS trialDan Jackson, Martin Jenkins, Enrico de Nigris, et al.
Pharmaceutical Statistics|May 19, 2015
Structured Benefit-risk assessment: a review of key publications and initiatives on frameworks and methodologiesShahrul Mt-Isa, Mario Ouwens, Veronique Robert, et al.
Pharmacoepidemiology and Drug Safety|November 24, 2025
Dimensionality Reduction Techniques for Improving Propensity Score Specification: An Application to a Cohort Study Using Claims DataSudhir Venkatesan, Jonatan Nåtman, Eva Lesén, et al.
Research Synthesis Methods|October 25, 2022
Network meta-interpolation: Effect modification adjustment in network meta-analysis using subgroup analysesOfir Harari, Mohsen Soltanifar, Joseph C Cappelleri, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 28, 2013
Cost-effectiveness and budget impact study of solvent/detergent (SD) treated plasma (octaplasLG®) versus fresh-frozen plasma (FFP) in any patient receiving transfusion in CanadaEline L Huisman, Margreet C van Eerd, J N Mario Ouwens, et al.
Current Therapeutic Research, Clinical and Experimental|September 6, 2021
Assessing the Influence of Subsequent Immunotherapy on Overall Survival in Patients with Unresectable Stage III Non-Small Cell Lung Cancer from the PACIFIC StudyMario Ouwens, Annie Darilay, Yiduo Zhang, et al.
Therapeutic Advances in Respiratory Disease|December 24, 2019
Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β<sub>2</sub>-agonist fixed-dose combinations in COPDMohd Kashif Siddiqui, Pragya Shukla, Martin Jenkins, et al.
F1000Research|September 19, 2018
Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?Sajan Khosla, Robert White, Jesús Medina, et al.
Journal of Comparative Effectiveness Research|January 10, 2020
Effectiveness of durvalumab versus chemotherapy in metastatic urothelial cancer: an observational, indirect comparisonBeth L Nordstrom, Mustafa Oguz, Bong Chul Chu, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Advances in Therapy|April 2, 2023
Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis"Jonathan Marshall, Akanksha Sharma, Patrick Darken, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 11, 2024
Associations between the EQ-5D-5L and exacerbations of chronic obstructive pulmonary disease in the ETHOS trialDan Jackson, Martin Jenkins, Enrico de Nigris, et al.
Pharmaceutical Statistics|May 19, 2015
Structured Benefit-risk assessment: a review of key publications and initiatives on frameworks and methodologiesShahrul Mt-Isa, Mario Ouwens, Veronique Robert, et al.
Pharmacoepidemiology and Drug Safety|November 24, 2025
Dimensionality Reduction Techniques for Improving Propensity Score Specification: An Application to a Cohort Study Using Claims DataSudhir Venkatesan, Jonatan Nåtman, Eva Lesén, et al.
Research Synthesis Methods|October 25, 2022
Network meta-interpolation: Effect modification adjustment in network meta-analysis using subgroup analysesOfir Harari, Mohsen Soltanifar, Joseph C Cappelleri, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 28, 2013
Cost-effectiveness and budget impact study of solvent/detergent (SD) treated plasma (octaplasLG®) versus fresh-frozen plasma (FFP) in any patient receiving transfusion in CanadaEline L Huisman, Margreet C van Eerd, J N Mario Ouwens, et al.
Current Therapeutic Research, Clinical and Experimental|September 6, 2021
Assessing the Influence of Subsequent Immunotherapy on Overall Survival in Patients with Unresectable Stage III Non-Small Cell Lung Cancer from the PACIFIC StudyMario Ouwens, Annie Darilay, Yiduo Zhang, et al.
Therapeutic Advances in Respiratory Disease|December 24, 2019
Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β<sub>2</sub>-agonist fixed-dose combinations in COPDMohd Kashif Siddiqui, Pragya Shukla, Martin Jenkins, et al.
F1000Research|September 19, 2018
Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?Sajan Khosla, Robert White, Jesús Medina, et al.
Journal of Comparative Effectiveness Research|January 10, 2020
Effectiveness of durvalumab versus chemotherapy in metastatic urothelial cancer: an observational, indirect comparisonBeth L Nordstrom, Mustafa Oguz, Bong Chul Chu, et al.
Pageof 5